The NAICS code for this procurement is 325412, Pharmaceutical and Medicine Manufacturing. Period of Performance, September 30, 2023 through September 29, 2026, including options and option quantities.

The Administration and strategic Preparedness and Response (ASPR), Division of Strategic National Stockpile (DSNS) awarded a sole source Firm Fixed Price contract to Partner Therapeutics located at 19 Muzzey Street Suite 105, Lexington, MA, 02421-5211

The Division of Strategic National Stockpile (DSNS), under the Administration and Strategic Preparedness and Response (ASPR), granted a sole source Firm Fixed Price contract to Partner Therapeutics. This contract, awarded for the acquisition of GM-CSF Leukine 250MCG/Vial Injectable NDC (71837-5843-05), was facilitated via VA Schedule No. 36F79718D059. It spans a 36-month period and aligns with provisions outlined in the Project BioShield Act of 2004, the Pandemic and All-Hazards Preparedness Act of 2006 (inclusive of subsequent reauthorizations in 2013 and 2019), and the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE). These directives mandate the SNS to procure, store, and dispense specific medical countermeasures, including those mitigating injuries stemming from various exposures such as physical, radiological, and nuclear elements.